Knowledge Hub

Global T-Cell Immunotherapy Market Research Report 2017

Press Release   •   Jan 31, 2017 07:13 EST

MarketResearchReports.biz has recently announced the addition of a market study “ Global T-Cell Immunotherapy Market Research Report 2017 ”, is a comparative analysis of the global market.

Notes:

Production, means the output of T-Cell Immunotherapy

Revenue, means the sales value of T-Cell Immunotherapy

This report studies T-Cell Immunotherapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Adaptimmune

Altor Bioscience Corporation

Cellectis

Cell Therapy Catapult

Juno Therapeutics

Kite Pharma

Novartis

Takara Bio

Unum Therapeutics

Abingworth

ARCH Venture Partners

Acorn Campus Ventures

Adaptimmune

AFA F?rs?kring

AGF Private Equity

AgonOx

Agreen Biotech

Aju IB Investment

Alaska Permanent Fund

Alexandria Ventures

Allos Therapeutics

Amgen

Applied Immune Technologies

Aquilo Capital Management

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of T-Cell Immunotherapy in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/931632

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

CAR-T

TCR

TIL Therapies

Split by application, this report focuses on consumption, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into

Hematological Malignancies

Solid Tumors

Others

Table Of Content

Global T-Cell Immunotherapy Market Research Report 2017

1 T-Cell Immunotherapy Market Overview

1.1 Product Overview and Scope of T-Cell Immunotherapy

1.2 T-Cell Immunotherapy Segment by Type

1.2.1 Global Production Market Share of T-Cell Immunotherapy by Type in 2015

1.2.2 CAR-T

1.2.3 TCR

1.2.4 TIL Therapies

1.3 T-Cell Immunotherapy Segment by Application

1.3.1 T-Cell Immunotherapy Consumption Market Share by Application in 2015

1.3.2 Hematological Malignancies

1.3.3 Solid Tumors

1.3.4 Others

1.4 T-Cell Immunotherapy Market by Region

1.4.1 North America Status and Prospect (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 China Status and Prospect (2012-2022)

1.4.4 Japan Status and Prospect (2012-2022)

1.4.5 Southeast Asia Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of T-Cell Immunotherapy (2012-2022)

2 Global T-Cell Immunotherapy Market Competition by Manufacturers

2.1 Global T-Cell Immunotherapy Production and Share by Manufacturers (2015 and 2016)

2.2 Global T-Cell Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global T-Cell Immunotherapy Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers T-Cell Immunotherapy Manufacturing Base Distribution, Sales Area and Product Type

2.5 T-Cell Immunotherapy Market Competitive Situation and Trends

2.5.1 T-Cell Immunotherapy Market Concentration Rate

2.5.2 T-Cell Immunotherapy Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global T-Cell Immunotherapy Production, Revenue (Value) by Region (2012-2017)

3.1 Global T-Cell Immunotherapy Production and Market Share by Region (2012-2017)

3.2 Global T-Cell Immunotherapy Revenue (Value) and Market Share by Region (2012-2017)

3.3 Global T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

3.4 North America T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

3.5 Europe T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

3.6 China T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

3.7 Japan T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Southeast Asia T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

3.9 India T-Cell Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

4 Global T-Cell Immunotherapy Supply (Production), Consumption, Export, Import by Regions (2012-2017)

4.1 Global T-Cell Immunotherapy Consumption by Regions (2012-2017)

4.2 North America T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

4.3 Europe T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

4.4 China T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

4.5 Japan T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

4.7 India T-Cell Immunotherapy Production, Consumption, Export, Import (2012-2017)

5 Global T-Cell Immunotherapy Production, Revenue (Value), Price Trend by Type

5.1 Global T-Cell Immunotherapy Production and Market Share by Type (2012-2017)

5.2 Global T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)

5.3 Global T-Cell Immunotherapy Price by Type (2012-2017)

5.4 Global T-Cell Immunotherapy Production Growth by Type (2012-2017)